ARTV
Income statement / Annual
Last year (2023), Artiva Biotherapeutics, Inc. Common Stock's total revenue was $33.49 M,
an increase of 579.21% from the previous year.
In 2023, Artiva Biotherapeutics, Inc. Common Stock's net income was -$27.70 M.
See Artiva Biotherapeutics, Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$33.49 M
|
$4.93 M
|
$2.00 M
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$33.49 M |
$4.93 M |
$2.00 M |
$0.00 |
| Gross Profit Ratio |
1 |
1 |
1 |
0 |
| Research and Development
Expenses |
$50.25 M
|
$43.98 M
|
$42.41 M
|
$13.85 M
|
| General & Administrative
Expenses |
$13.91 M
|
$20.78 M
|
$12.86 M
|
$4.43 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$13.91 M
|
$20.78 M
|
$12.86 M
|
$4.43 M
|
| Other Expenses |
$0.00 |
$200,000.00 |
-$18.55 M |
$477,000.00 |
| Operating Expenses |
$64.16 M |
$64.76 M |
$55.27 M |
$18.27 M |
| Cost And Expenses |
$64.16 M |
$64.76 M |
$55.27 M |
$18.27 M |
| Interest Income |
$2.54 M |
$1.29 M |
$0.00 |
$2,000.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$199,000.00 |
| Depreciation &
Amortization |
$2.27 M
|
$1.16 M
|
$248,000.00
|
$73,000.00
|
| EBITDA |
-$28.41 M
|
-$58.67 M
|
-$71.58 M
|
-$17.72 M
|
| EBITDA Ratio |
-0.85 |
-11.9 |
-35.75 |
0 |
| Operating Income Ratio
|
-0.92
|
-12.13
|
-26.61
|
0
|
| Total Other
Income/Expenses Net |
$3.05 M
|
$1.49 M
|
-$18.55 M
|
$280,000.00
|
| Income Before Tax |
-$27.62 M |
-$58.34 M |
-$71.83 M |
-$17.99 M |
| Income Before Tax Ratio
|
-0.82
|
-11.83
|
-35.88
|
0
|
| Income Tax Expense |
$72,000.00 |
$53,000.00 |
-$18.55 M |
$676,000.00 |
| Net Income |
-$27.70 M |
-$58.39 M |
-$71.83 M |
-$17.99 M |
| Net Income Ratio |
-0.83 |
-11.84 |
-35.88 |
0 |
| EPS |
-2.96 |
-3.32 |
-4.08 |
-1.02 |
| EPS Diluted |
-2.96 |
-3.32 |
-4.08 |
-1.02 |
| Weighted Average Shares
Out |
$9.35 M
|
$17.58 M
|
$17.58 M
|
$17.58 M
|
| Weighted Average Shares
Out Diluted |
$9.35 M
|
$17.58 M
|
$17.58 M
|
$17.58 M
|
| Link |
|
|
|
|
